UPDATED Apr 26, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
LLY | US$733.51 | 1.0% | 85.3% | US$660.7b | US$813.32 | PE126.1x | E27.2% | 0.7% | Pharmaceuticals & Biotech | ||
UNH | US$495.35 | -1.2% | 0.7% | US$455.8b | US$567.36 | PE29.7x | E19.2% | 1.5% | Healthcare | ||
JNJ | US$146.14 | -1.2% | -10.7% | US$352.2b | US$173.60 | PE18.4x | E5.1% | 3.4% | Pharmaceuticals & Biotech | ||
MRK | US$131.20 | 4.3% | 13.6% | US$332.3b | US$140.12 | PE144.1x | E25.9% | 2.3% | Pharmaceuticals & Biotech | ||
ABBV | US$159.62 | -4.1% | 5.6% | US$282.6b | US$183.73 | PE47.5x | E24.2% | 3.9% | Pharmaceuticals & Biotech | ||
TMO | US$573.60 | 5.3% | 3.4% | US$219.0b | US$618.21 | PE36.3x | E12.0% | 0.3% | Pharmaceuticals & Biotech | ||
ABT | US$107.53 | 0.2% | -2.7% | US$186.6b | US$126.33 | PE33.3x | E11.3% | 2.0% | Healthcare | ||
DHR | US$246.58 | 4.7% | 4.1% | US$182.6b | US$269.22 | PE44.9x | E13.5% | 0.4% | Pharmaceuticals & Biotech | ||
AMGN | US$269.98 | 0.4% | 12.6% | US$144.8b | US$300.27 | PE21.6x | E8.9% | 3.3% | Pharmaceuticals & Biotech | ||
PFE | US$25.40 | -2.3% | -34.7% | US$143.8b | US$31.62 | PE67.4x | E22.3% | 6.6% | Pharmaceuticals & Biotech | ||
ISRG | US$375.33 | 2.5% | 24.6% | US$133.1b | US$420.28 | PE67x | E11.5% | n/a | Healthcare | ||
SYK | US$335.61 | 3.1% | 12.0% | US$127.6b | US$365.69 | PE40.3x | E12.7% | 1.0% | Healthcare | ||
ELV | US$537.26 | 1.1% | 14.6% | US$124.9b | US$599.48 | PE20x | E12.5% | 1.2% | Healthcare | ||
BSX | US$73.17 | 8.7% | 40.4% | US$107.6b | US$80.08 | PE60.9x | E18.1% | n/a | Healthcare | ||
MDT | US$79.74 | 0.3% | -12.3% | US$105.9b | US$94.75 | PE25.2x | E10.3% | 3.5% | Healthcare | ||
VRTX | US$397.48 | 0.8% | 16.7% | US$102.7b | US$459.72 | PE28.4x | E11.5% | n/a | Pharmaceuticals & Biotech | ||
CI | US$354.47 | 0.6% | 39.9% | US$100.5b | US$381.44 | PE19.5x | E9.6% | 1.6% | Healthcare | ||
REGN | US$883.20 | -1.5% | 10.2% | US$95.3b | US$1,038.08 | PE24.1x | E11.2% | n/a | Pharmaceuticals & Biotech | ||
BMY | US$44.85 | -8.3% | -32.8% | US$90.9b | US$54.02 | PS2x | E44.3% | 5.4% | Pharmaceuticals & Biotech | ||
CVS | US$67.18 | -3.7% | -8.4% | US$84.7b | US$88.15 | PE10.1x | E6.9% | 4.0% | Healthcare | ||
GILD | US$65.42 | -2.0% | -20.4% | US$81.6b | US$84.25 | PE168.2x | E33.6% | 4.7% | Pharmaceuticals & Biotech | ||
HCA | US$306.69 | 0.5% | 6.7% | US$81.1b | US$341.19 | PE14.8x | E6.0% | 0.9% | Healthcare | ||
ZTS | US$158.42 | 8.1% | -9.9% | US$72.4b | US$215.18 | PE30.9x | E8.1% | 1.1% | Pharmaceuticals & Biotech | ||
MCK | US$543.30 | 3.5% | 49.2% | US$71.4b | US$559.53 | PE23.8x | E8.7% | 0.5% | Healthcare |